FDA Approves Bayer’s Low-Dose MRI Contrast Agent
The new agent is indicated for visualizing lesions in the central nervous system and other body regions for adult and pediatric patients.
The new agent is indicated for visualizing lesions in the central nervous system and other body regions for adult and pediatric patients.
A study of 110,000 women identified a correlation between GLP-1 use and reduced breast cancer incidence, though researchers caution the findings do not establish causation.
Researchers found that neither radiologists nor leading AI models could consistently distinguish real from AI-generated X-rays, highlighting emerging risks in medical imaging and cybersecurity.
The ACP issued new guidance recommending biennial screening mammography for asymptomatic, average-risk women ages 50 to 74.